Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2014 2
2015 1
2017 1
2018 1
2019 1
2020 1
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Physiological lentiviral vectors for the generation of improved CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Muñoz P, Cortijo-Gutiérrez M, Pavlovic K, Jiménez-Moreno R, Nogueras S, Carmona MD, Sánchez-Hernández S, Aguilar-González A, Castella M, Juan M, Marañón C, Marchal JA, Benabdellah K, Herrera C, Martin F. Tristán-Manzano M, et al. Mol Ther Oncolytics. 2022 May 18;25:335-349. doi: 10.1016/j.omto.2022.05.003. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35694446 Free PMC article.
Chemical Variation and Pharmacological Properties of Dyssodia decipiens Essential Oil.
Pacheco-Hernández Y, Sánchez-Hernández GR, Reyes-Cervantes E, Romero-Arenas O, Pérez-Xochipa I, Villa-Ruano N. Pacheco-Hernández Y, et al. Chem Biodivers. 2020 Oct;17(10):e2000487. doi: 10.1002/cbdv.202000487. Epub 2020 Sep 25. Chem Biodivers. 2020. PMID: 32749064
The repellent activity of leaf essential oils (20 %) was effective within 1-5 h post-treatment (>90 %) and it was stronger (p<0.01) than that of commercial DEET. The evaluation of the four major volatiles (10 % each) produced similar results to those of essential oil …
The repellent activity of leaf essential oils (20 %) was effective within 1-5 h post-treatment (>90 %) and it was stronger (p<0 …
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study.
Quiroga B, Soler MJ, Ortiz A, Jaravaca Mantecón CJ, Nava Pérez N, Serra Martín M, Sato Y, Marin Franco AJ, Pazmiño Zambrano DF, Lucena Valverde R, Ortega Diaz M, Calderón González C, Cazorla López JM, Pereira M, González Parra E, Sánchez Horrillo A, Sánchez González C, Toapanta N, Cigarrán Guldris S, Sánchez Hernández R, Pizarro Sánchez S, Muñiz Rincón M, Garcia-Fernández N, Blanco Castro N, Collantes Mateo R, Quiroz Morales MA, Escamilla-Cabrera B, Berdud Godoy I, Gil-Casares Casanova B, Leyva A, Rojas J, Gansevoort RT, de Sequera P; SENCOVAC collaborative network. Quiroga B, et al. Clin Kidney J. 2022 Jul 26;15(10):1856-1864. doi: 10.1093/ckj/sfac169. eCollection 2022 Oct. Clin Kidney J. 2022. PMID: 36147708 Free PMC article.
At 6 months, 64 (9%) patients had negative anti-Spike antibody titers (3% of early booster and 29% of late booster patients, P = .001). At 9 months, 91% of patients with 6-month negative response had seroconverted and there were no differences in residual prevalence of neg …
At 6 months, 64 (9%) patients had negative anti-Spike antibody titers (3% of early booster and 29% of late booster patients, P = .001 …
Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain.
Garralda Fernandez J, Molero Vilches I, Bermejo Rodríguez A, Cano Torres I, Colino Romay EI, García Arata I, Jaqueti Aroca J, Lillo Rodríguez R, López Lacomba D, Mazón Cuadrado L, Molina Esteban L, Morales García LJ, Moratilla Monzo L, Nieto-Borrajo E, Pacheco Delgado M, Prieto Menchero S, Sánchez Hernández C, Sánchez Testillano E, García-Martínez J. Garralda Fernandez J, et al. PLoS One. 2021 Jan 14;16(1):e0245001. doi: 10.1371/journal.pone.0245001. eCollection 2021. PLoS One. 2021. PMID: 33444392 Free PMC article.
SARS-CoV-2 IgG-positive patients in whom the virus was not detected were 221 (9.1%); up to 151 of them (68.3%) did not report any compatible symptoms nor consult at the OHS for this reason. Men became more infected than women (25% vs 18.5%, p = 0.0009), including when data …
SARS-CoV-2 IgG-positive patients in whom the virus was not detected were 221 (9.1%); up to 151 of them (68.3%) did not report any compatible …
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
Ariza MJ, Rioja J, Ibarretxe D, Camacho A, Díaz-Díaz JL, Mangas A, Carbayo-Herencia JA, Ruiz-Ocaña P, Lamíquiz-Moneo I, Mosquera D, Sáenz P, Masana L, Muñiz-Grijalvo O, Pérez-Calahorra S, Valdivielso P; Spanish Dyslipidemia Registry. Ariza MJ, et al. J Clin Lipidol. 2018 Nov-Dec;12(6):1482-1492.e3. doi: 10.1016/j.jacl.2018.07.013. Epub 2018 Aug 1. J Clin Lipidol. 2018. PMID: 30150141
The molecular analysis revealed 3 novel mutations: 2 in LPL, in 2 unrelated patients (c.312delA; p.Asp105Thrfs*66 and c.629A>G; p.His210Arg), and 1 in GPHIBP1 in a third patient (c.502delC; p.Leu168Serfs*83). ...Among these, we found 2 novel mutations in A …
The molecular analysis revealed 3 novel mutations: 2 in LPL, in 2 unrelated patients (c.312delA; p.Asp105Thrfs*66 and c.629A>G; …
[Orthogeriatrics: The First multicentre regional register of hip fractures in Castilla y León (Spain)].
Muñoz-Pascual A, Sáez-López P, Jiménez-Mola S, Sánchez-Hernández N, Alonso-García N, Andrés-Sainz AI, Macias-Montero MC, Vázquez-Pedrezuela C, Pereira de Castro Juez N, Del Pozo-Tagarro P, Pablos-Hernández C, Cervera-Díaz C, Cerón-Fernández A, Vuelta-Calzada E, Perez-Jara Carrera J, González-Ramírez A, Collado-Díaz T, Idoate-Gil J, Guerrero-Díaz MT, Gutierrez-Bejarano D, Martín-Perez E. Muñoz-Pascual A, et al. Rev Esp Geriatr Gerontol. 2017 Sep-Oct;52(5):242-248. doi: 10.1016/j.regg.2017.03.001. Epub 2017 May 15. Rev Esp Geriatr Gerontol. 2017. PMID: 28522074 Spanish.
In-hospital mortality was 4.6%. The mean pre-surgical stay was related to the overall stay: P<.001. CONCLUSIONS: Hip fracture registers are an essential tool for evaluating the process and for improving the treatment quality of these patients. ...
In-hospital mortality was 4.6%. The mean pre-surgical stay was related to the overall stay: P<.001. CONCLUSIONS: Hip fracture regi …
Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population.
Gómez-Bañuelos E, Martín-Márquez BT, Martínez-García EA, Figueroa-Sanchez M, Nuñez-Atahualpa L, Rocha-Muñoz AD, Sánchez-Hernández PE, Navarro-Hernandez RE, Madrigal-Ruiz PM, Saldaña-Millan AA, Duran-Barragan S, Gonzalez-Lopez L, Gamez-Nava JI, Vázquez-Del Mercado M. Gómez-Bañuelos E, et al. Biomed Res Int. 2014;2014:736786. doi: 10.1155/2014/736786. Epub 2014 Jun 9. Biomed Res Int. 2014. PMID: 25006585 Free PMC article.
METHODS: We included 67 patients with RA from the Rheumatology Department of Hospital Civil "Dr. Juan I. Menchaca," Guadalajara, Jalisco, Mexico. We evaluated the cIMT, considering subclinical atherosclerosis when >0.6 mm. ...RESULTS: We found low CD36 membrane expressi …
METHODS: We included 67 patients with RA from the Rheumatology Department of Hospital Civil "Dr. Juan I. Menchaca," Guadalajara, Jali …
Intercalated Dosing Schedule of Erlotinib and Docetaxel as a Therapeutic Strategy to Avoid Antagonism and Optimize Its Benefits in Advanced Non-Small-Cell Lung Cancer. A Randomized Phase II Clinical Trial.
Juan Ó, Aparisi F, Sánchez-Hernández A, Muñoz-Langa J, Esquerdo G, García-Sánchez J, López A, Garde J, Giner V. Juan Ó, et al. Clin Lung Cancer. 2015 May;16(3):193-9. doi: 10.1016/j.cllc.2014.11.006. Epub 2014 Nov 23. Clin Lung Cancer. 2015. PMID: 25547902 Clinical Trial.
Median progression-free survival (PFS) was 3.0 versus 2.1 months (hazard ratio [HR], 0.65; 95% confidence interval [CI], 0.39-1.06; P = .086). Median overall survival (OS) was 7.5 and 5.2 months (HR, 0.70; 95% CI, 0.41-1.19; P = .19). ...
Median progression-free survival (PFS) was 3.0 versus 2.1 months (hazard ratio [HR], 0.65; 95% confidence interval [CI], 0.39-1.06; P …
11 results